LyoGenesis Plus

LyoGenesis Plus is a Wisconsin-incorporated healthcare services company formed to acquire and consolidate pharmaceutical services businesses, particularly CDMO assets. Public disclosures in May 2026 indicate that it entered into an agreement to acquire MPP Group LLC, an FDA-registered, cGMP-compliant contract development and manufacturing organization in Mequon, Wisconsin. Through that asset base, LyoGenesis Plus is positioned around pharmaceutical-grade peptide formulation, analytical development, aseptic manufacturing, and related drug delivery manufacturing support rather than proprietary therapeutic drug discovery. The company appears to function as an operating and holding platform for manufacturing infrastructure serving pharma and biotech customers. It was founded by Tommy Thompson and Bill Jackson and was described as well-capitalized with equipment and receivables financing in connection with Vector Science & Therapeutics' option to invest.